SCHEMBL27143232

SCHEMBL27143232

Cc1ccc(S(=O)(=O)CCCC2CCN(C(=O)O)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
KMT2A Q03164 2/20 0.46
HSD17B10 Q99714 1/20 0.45
MAPK1 P28482 1/20 0.43
GPR119 Q8TDV5 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
HTT P42858 2/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
YAP1 P46937 1/20 0.41
TEAD4 Q15561 1/20 0.41
F10 P00742 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27137179 0.84 GPR119 (0.62) KMT2AGPR119MEN1
SCHEMBL30020119 0.82 GPR119 (0.48) ALDH1A1KMT2AGPR119KDM4ELMNA
SCHEMBL19834817 0.81 GPR119 (0.49) ALDH1A1KMT2AGPR119KDM4ELMNA
SCHEMBL2389377 0.80 ALDH1A1 (0.45) ALDH1A1KMT2AGPR119KDM4ELMNA
SCHEMBL7459127 0.79 ALDH1A1 (0.61) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL6011397 0.79 MEN1 (0.44) ALDH1A1KMT2AGPR119MEN1SMN1; SMN2
SCHEMBL25268900 0.79 KMT2A (0.48) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL25274092 0.78 GPR119 (0.57) KMT2AGPR119MEN1
SCHEMBL8171108 0.77 ALDH1A1 (0.57) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL28978030 0.77 GPR119 (0.58) KMT2AGPR119MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4328219-A1 SOS1 DEGRADING AGENT AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shanghai Leadingtac Pharmaceutical Co. Ltd. (CN) 2024-02-28 EP disclosed